Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 87 Dimensions

Readers on

mendeley: 81 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 2,618 followers.

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors. - PubMed - NCBI https://t.co/Ot4ZdRRuHk #hvhebron #onco @SpringerNature

01 Apr 2019

Reply Repost Favourite

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors. https://t.co/4yFpdUYCtX

29 Mar 2019

Reply Repost Favourite

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors. - PubMed - NCBI https://t.co/Ot4ZdRRuHk #hvhebron #onco @SpringerNature

08 Feb 2019

Reply Repost Favourite

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors. https://t.co/Io9GBSiJY3

07 Feb 2019

Reply Repost Favourite